SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma receives warning letter from USFDA

23 May 2011 Evaluate

Aurobindo Pharma after being issued an alert for its unit VI, which makes oral and sterile (or injectable) cephalosporins, has now received the warning letter from US Food & Drug Administration (USFDA) detailing their observations.

In addition, based on a field alert report for packaging and labeling compliance for unit III, the USFDA has also asked the company for submission of a detailed action plan for improvement in this letter. This action plan is required to be submitted within 15 working days and USFDA has also given an opportunity for regulatory meeting at their office.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, WHO, Health Canada, MCC South Africa, ANVISA Brazil. The company’s robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up.

Aurobindo Pharma Share Price

1406.65 15.50 (1.11%)
22-Apr-2026 11:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.10
Dr. Reddys Lab 1219.70
Cipla 1231.30
Zydus Lifesciences 930.20
Lupin 2313.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×